Abstract
Purpose
To study interactions between nonsteroidal anti-inflammatory drugs (NSAIDs) and membrane mimetic models.
Methods
The interactions of indomethacin and nimesulide with liposomes of dipalmitoylphosphatidylcholine (DPPC) at two physiological pH conditions (pH 7.4 and 5.0) were investigated by time-resolved and steady-state fluorescence techniques and derivative ultraviolet/visible absorption spectrophotometry. Fluorescence quenching studies that assess the location of the drugs interacting with the membrane were carried out using labeled liposomes with trimethylammonium-diphenylhexatriene (TMA-DPH), a fluorescent probe with well-known membrane localization. Partition of the drugs within membranes was determined by calculating their partition coefficients (K p ) between liposomes and water using derivative ultraviolet/visible absorption spectrophotometry in a temperature range of 37–50°C. The Van’t Hoff analysis of the temperature dependence of K p values allowed calculating the membrane-water variation of enthalpy (ΔH w→m) and entropy (ΔS w→m) and consequently the Gibbs free energy (ΔG w→m).
Results
Results indicate that quenching, partitioning and thermodynamic parameters inherent to the interaction of the studied drugs with the membrane mimetic model are deeply dependent on the initial organization of the membrane, on the pH medium and on the physical properties of the drug.
Conclusions
The interactions between NSAIDs and membranes are manifested as changes in the physical and thermodynamic properties of the bilayers. Depending on the composition and physical state of the membrane and the chemical structure of the NSAID, the interaction can support or prevent drug activity or toxicity.
Similar content being viewed by others
References
Lucio M, Lima JLFC, Reis S. Drug-membrane interactions: significance for medicinal chemistry. Curr Med Chem. 2010;17(17):1795–809.
Escriba PV. Membrane-lipid therapy: a new approach in molecular medicine. Trends Mol Med. 2006;12(1):34–43.
Seydel JK, Wiese M. Drug-membrane interactions: Analysis, drug distribution, modeling, Wiley-VCH, 2002.
Weissig V. Liposomes methods and protocols. London: Humana Press; 2010.
Lichtenberger LM, Zhou Y, Dial EJ, Raphael RM. NSAID injury to the gastrointestinal tract: evidence that NSAIDs interact with phospholipids to weaken the hydrophobic surface barrier and induce the formation of unstable pores in membranes. J Pharm Pharmacol. 2006;58(11):1421–8.
Lucio M, Ferreira H, Lima JLFC, Matos C, de Castro B, Reis S. Influence of some anti-inflammatory drugs in membrane fluidity studied by fluorescence anisotropy measurements. Phys Chem Chem Phys. 2004;6(7):1493–8.
Lucio M, Nunes C, Gaspar D, Golebska K, Wisniewski M, Lima JLFC, et al. Effect of anti-inflammatory drugs in phosphatidylcholine membranes: a fluorescence and calorimetric study. Chem Phys Lett. 2009;471(4–6):300–9.
van den Hoven JM, Van Tomme SR, Metselaar JM, Nuijen B, Beijnen JH, Storm G. Liposomal drug formulations in the treatment of rheumatoid arthritis. Mol Pharm. 2011;8(4):1002–15.
Lichtenberger LM. Where is the evidence that cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited. Biochem Pharmacol. 2001;61(6):631–7.
van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol. 2008;9(2):112–24.
Escriba PV, Gonzalez-Ros JM, Goni FM, Kinnunen PKJ, Vigh L, Sanchez-Magraner L, et al. Membranes: a meeting point for lipids, proteins and therapies. J Cell Mol Med. 2008;12(3):829–75.
Kaneko T, Matsui H, Shimokawa O, Nakahara A, Hyodo I. Cellular membrane fluidity measurement by fluorescence polarization in indomethacin-induced gastric cellular injury in vitro. J Gastroenterol. 2007;42(12):939–46.
Lichtenberger LM, Zhou Y, Jayaraman V, Doyen JR, O’Neil RG, Dial EJ, et al. Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: Characterization of interaction of NSAIDs with phosphatidylcholine. Biochim Biophys Acta-Mol Cell Biol Lipids. 2012;1821(7):994–1002.
Lichtenberger LM, Wang ZM, Romero JJ, Ulloa C, Perez JC, Giraud MN, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nat Med. 1995;1(2):154–8.
Lichtenberger LM, Graziani LA, Dial EJ, Butler BD, Hills BA. Role of surface-active phospholipids in gastric cytoprotection. Science. 1983;219(4590):1327–9.
Lichtenberger LM. The hydrophobic barrier properties of gastrointestinal mucus. Annu Rev Physiol. 1995;57:565–83.
Brzozowski T. Nonsteroidal anti-inflammatory drug-induced experimental gastropathy: is gastric acid the major trigger? Clin Exp Pharmacol Physiol. 2010;37(7):651–3.
da Silva AMG, Romao RIS. Mixed monolayers involving DPPC, DODAB and oleic acid and their interaction with nicotinic acid at the air-water interface. Chem Phys Lipids. 2005;137(1–2):62–76.
Allen A, Pearson JP. The gastrointestinal adherent mucous gel barrier. In: Corfield AP, editor. Glycoprotein methods and protocols - The Mucins, Vol. 125. Totowa: Humana Press; 2000. p. 57–64.
Mosnier P, Rayssiguier Y, Motta C, Pelissier E, Bommelaer G. Effect of ethanol on rat gastric surfactant: a fluorescence polarization study. Gastroenterology. 1993;104(1):179–84.
Jordan O, Butoescu N, Doelker E. Intra-articular drug delivery systems for the treatment of rheumatic diseases: a review of the factors influencing their performance. Eur J Pharm Biopharm. 2009;73(2):205–18.
Ferreira H, Lúcio M, Lima JLFC, Cordeiro-da-Silva A, Tavares J, Reis S. Effect of anti-inflammatory drugs on splenocyte membrane fluidity. Anal Biochem. 2005;339(1):144–9.
Gaspar D, Lucio M, Wagner K, Brezesinski G, Rocha S, Lima JLFC, et al. A biophysical approach to phospholipase A(2) activity and inhibition by anti-inflammatory drugs. Biophys Chem. 2010;152(1–3):109–17.
Sousa C, Nunes C, Lucio M, Ferreira H, Lima JLFC, Tavares J, et al. Effect of nonsteroidal anti-inflammatory drugs on the cellular membrane fluidity. J Pharm Sci. 2008;97(8):3195–206.
Nunes C, Brezesinski G, Pereira-Leite C, Lima JLFC, Reis S, Lucio M. NSAIDs interactions with membranes: a biophysical approach. Langmuir. 2011;27(17):10847–58.
Pereira-Leite C, Nunes C, Lima JLFC, Reis S, Lucio M. Interaction of celecoxib with membranes: the role of membrane biophysics on its therapeutic and toxic effects. J Phys Chem B. 2012;116(46):13608–17.
Nunes C, Brezesinski G, Lima JLFC, Reis S, Lucio M. Synchrotron SAXS and WAXS study of the interactions of NSAIDs with lipid membranes. J Phys Chem B. 2011;115(24):8024–32.
Nunes C, Brezesinski G, Lopes D, Lima JLFC, Reis S, Lucio M. Lipid-drug interaction: biophysical effects of tolmetin on membrane mimetic systems of different dimensionality. J Phys Chem B. 2011;115(43):12615–23.
Panicker L, Mishra KP. Influence of salicylic acid on the biophysical properties of dipalmitoyl phosphatidylcholine vesicles. Phase Transit. 2008;81(1):65–76.
Balimane PV, Chong SH, Morrison RA. Current methodologies used for evaluation of intestinal permeability and absorption. J Pharm Toxicol Methods. 2000;44(1):301–12.
Ho C, Slater SJ, Stubbs CD. Hydration and order in lipid bilayers. Biochemistry-Us. 1995;34(18):6188–95.
Lasic DD, Needham D. The “stealth” liposome: a prototypical biomaterial. Chem Rev. 1995;95:2601–28.
Hope MJ, Bally MB, Webb G, Cullis PR. Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to mantain a membrane potential. Biochim Biophys Acta. 1985;812:55–65.
Savitzky A, Golay MJE. Smoothing and differentiation of data. Anal Chem. 1964;36:1627–39.
Magalhaes LM, Nunes C, Lucio M, Segundo MA, Reis S, Lima JLFC. High-throughput microplate assay for the determination of drug partition coefficients. Nat Protoc. 2010;5(11):1823–30.
Coutinho A, Prieto M. Ribonuclease T1 and alcohol dehydrogenase fluorescence quenching by acrylamide. J Chem Educ. 1993;70:425.
Amin K, Wasan KM, Albrecht RM, Heath TD. Cell association of liposomes with high fluid anionic phospholipid content is mediated specifically by LDL and its receptor, LDLr. J Pharm Sci. 2002;91(5):1233–44.
Koynova R, Koumanov A, Tenchov B. Metastable rippled gel phase in saturated phosphatidylcholines: calorimetric and densitometric characterization. Bba-Biomembr. 1996;1285(1):101–8.
Chakraborty H, Roy S, Sarkar M. Interaction of oxicam NSAIDs with DMPC vesicles: differential partitioning of drugs. Chem Phys Lipids. 2005;138(1–2):20–8.
Kundu S, Chakraborty H, Sarkar M, Datta A. Interaction of Oxicam NSAIDs with lipid monolayer: anomalous dependence on drug concentration. Colloid Surface B. 2009;70(1):157–61.
Lozano HR, Martínez F. Thermodynamics of partitioning and solvation of ketoprofen in some organic solvent/buffer and liposome systems. Braz J Pharm Sci. 2006;42(4):601–13.
Lakowicz JR. Principles of fluorescence spectroscopy. New York: Springer; 2006.
Illinger D, Duportail G, Mely Y, Poirelmorales N, Gerard D, Kuhry JG. A comparison of the fluorescence properties of Tma-Dph as a probe for plasma-membrane and for endocytic membrane. Bba-Biomembr. 1995;1239(1):58–66.
Kovacs E, Savopol T, Iordache MM, Saplacan L, Sobaru I, Istrate C, et al. Interaction of gentamicin polycation with model and cell membranes. Bioelectrochemistry. 2012;87:230–5.
Monteiro JP, Martins AF, Lucio M, Reis S, Pinheiro TJT, Geraldes CFGC, et al. Nimesulide interaction with membrane model systems: are membrane physical effects involved in nimesulide mitochondrial toxicity? Toxicol Vitr. 2011;25(6):1215–23.
Monteiro JP, Martins AF, Lucio M, Reis S, Geraldes CFGC, Oliveira PJ, et al. Interaction of carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP) with lipid membrane systems: a biophysical approach with relevance to mitochondrial uncoupling. J Bioenerg Biomembr. 2011;43(3):287–98.
Brittes J, Lucio M, Nunes C, Lima JLFC, Reis S. Effects of resveratrol on membrane biophysical properties: relevance for its pharmacological effects. Chem Phys Lipids. 2010;163(8):747–54.
Acknowledgments and Disclosures
Cláudia Nunes and Marina Pinheiro thank FCT (Fundação para a Ciência e Tecnologia) for the Post-Doc Grant (SFRH/BPD/81963/2011) and Doc Grant (SFRH/BD/63318/2009), respectively.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nunes, C., Lopes, D., Pinheiro, M. et al. In Vitro Assessment of NSAIDs-Membrane Interactions: Significance for Pharmacological Actions. Pharm Res 30, 2097–2107 (2013). https://doi.org/10.1007/s11095-013-1066-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-013-1066-8